The invention relates to the use of a compound selected from:
[&agr;-(tert-butylaminomethyl)-3,4-dichlorobenzyl]thioacetamide and its laevorotatory isomer,
[&agr;-(tert-amylaminomethyl)-3,4-dichlorobenzyl]thioacetamide and its isomers,
[&agr;-(1-adamantylaminomethyl)3,4-dichlorobenzyl]thioacetamide and its isomers, as well as the addition salts of these compounds with pharmaceutically acceptable acids, for inhibiting dopamine reuptake.
本发明涉及使用以下化合物之一:[&agr;-(叔丁基
氨甲基)-3,4-二
氯苯甲基]
硫代乙酰胺及其左旋异构体,[&agr;-(叔戊基
氨甲基)-3,4-二
氯苯甲基]
硫代乙酰胺及其异构体,[&agr;-(1-
金刚烷基
氨甲基)3,4-二
氯苯甲基]
硫代乙酰胺及其异构体,以及这些化合物与药用可接受酸的加合盐,用于抑制
多巴胺的再摄取。